It can take 10–15 years and – accounting for development failures – cost over $500 million ... target-agnostic approaches to drug discovery. The bottleneck has shifted – to one of prioritization. “The ...

Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

“So, we need to increase efficiency on the process development side. While automation is one way of doing that, a much more efficient solution is to use in silico process development data to increase ...

Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound GK470 (AVX235), and the discovery of a more potent and selective lead, GK420 (AVX420), with significant ...

let’s de-risk the messy business of drug discovery, find promising targets, and then sell them to pharma to carry out the expensive process of development, getting bonus payments if the drug ...

Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

The author of the seminal cancer biography The Emperor Of All Maladies and the co-founder of LinkedIn are looking to connect ...

LinkedIn co-founder Reid Hoffman and famed oncologist Dr. Siddhartha Mukherjee have raised a whopping $24.6 million in a seed ...